GF
GRCL

Gabelli Funds’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Gabelli Funds’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-39,850
Closed -$400K – 1146
2023
Q4 		$400K Buy
+39,850
New +$400K ﹤0.01% 921